Avraham Pharmaceuticals Ltd logo

Avraham Pharmaceuticals Ltd

Avraham Pharmaceuticals is a clinical-stage company focused on developing small molecule therapeutics for the treatment of neurodegenerative disorders.

Avrahams lead product candidate, Ladostigil, was exclusively in-licensed from the Hebrew University and Technion Research and Development Foundation Ltd. and company was founded by the inventors of Ladostigil; Prof Marta Weinstock-Rosin, Prof. Moussa B.H. Youdim and Prof. Michael Chorev.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.avphar.com
Founded2010
Disease Focus
Development Stage
STOCK CODENon Listed
Address
42 Hayarkon st.Northern Industrial Zone, 81227
Yavneh
Israel
Email
Contact Number
+97 28 9324000

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/avraham-pharmaceuticals” connections=”true” suffix=””]

In Feb 2016, Avraham closed an investment round of approx. $4.0 Mn and has raised $18 Mn since formation. Key investors includes Yissum Research Development Company, Pontifax, Clal Biotechnology Industries, Integra Holdings, Yissums biotech holdings company, TRDF and others.